Cargando…
The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles
In oncogenetics, some patients could be considered as “extreme phenotypes”, such as those with very early onset presentation or multiple primary malignancies, unusually high numbers of cancers of the same spectrum or rare cancer types in the same parental branch. For these cases, a genetic predispos...
Autores principales: | Chevarin, Martin, Alcantara, Diana, Albuisson, Juliette, Collonge-Rame, Marie-Agnès, Populaire, Céline, Selmani, Zohair, Baurand, Amandine, Sawka, Caroline, Bertolone, Geoffrey, Callier, Patrick, Duffourd, Yannis, Jonveaux, Philippe, Bignon, Yves-Jean, Coupier, Isabelle, Cornelis, François, Cordier, Christophe, Mozelle-Nivoix, Monique, Rivière, Jean-Baptiste, Kuentz, Paul, Thauvin, Christel, Boidot, Romain, Ghiringhelli, François, O'Driscoll, Marc, Faivre, Laurence, Nambot, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904323/ https://www.ncbi.nlm.nih.gov/pubmed/36749285 http://dx.doi.org/10.18632/oncotarget.28358 |
Ejemplares similares
-
Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients
por: Mazel, Benoit, et al.
Publicado: (2023) -
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
por: Eliade, Marie, et al.
Publicado: (2016) -
Interest of exome sequencing trio‐like strategy based on pooled parental DNA for diagnosis and translational research in rare diseases
por: Tran Mau‐Them, Frederic, et al.
Publicado: (2021) -
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
por: Lecuelle, Julie, et al.
Publicado: (2021) -
Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer
por: Galland, Loïck, et al.
Publicado: (2023)